The ever-increasing complexity of health care products requires a data driven, evidence based approach to their regulation. Regulatory Science Ireland (RSI), a national response to these developments, is a network of interested parties from;
RSI’s mission is to unite stakeholders, including Academia, Pharmaceutical and Medtech industries, the Regulator and Government agencies, in the pursuit of an
integrated Irish response to global Regulatory Science initiatives that are beneficial to the patient.
RSI will fulfil its mission through facilitation of relevant research, training and communication, thereby creating an environment that:
RSI NEWS FEED:
The RSI biosimilar project team have recently published in Regulatory Toxicology and Pharmacology
Follow the link to read
RSI is committed to the development of an integrated Irish response to the global Regulatory Science effort by establishing an environment through which relevant research, training and communication creates a cohort of Irish based Regulatory Science experts and further strengthens the value proposition of Ireland as an attractive location for Health Care Products.
The RSI Board Of Directors creates an annual work plan in the following three areas.